These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36752450)

  • 1. Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden Deaths.
    Ramakrishna S; Salazar JW; Olgin JE; Moffatt E; Tseng ZH
    JACC Clin Electrophysiol; 2023 Mar; 9(3):403-413. PubMed ID: 36752450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death: POST SCD Study.
    Tseng ZH; Olgin JE; Vittinghoff E; Ursell PC; Kim AS; Sporer K; Yeh C; Colburn B; Clark NM; Khan R; Hart AP; Moffatt E
    Circulation; 2018 Jun; 137(25):2689-2700. PubMed ID: 29915095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the World Health Organization Definition: Predicting Autopsy-Defined Sudden Arrhythmic Deaths Among Presumed Sudden Cardiac Deaths in the POST SCD Study.
    Tseng ZH; Salazar JW; Olgin JE; Ursell PC; Kim AS; Bedigian A; Probert J; Hart AP; Moffatt E; Vittinghoff E
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007171. PubMed ID: 31248279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homelessness and Incidence and Causes of Sudden Death: Data From the POST SCD Study.
    Haghighat L; Ramakrishna S; Salazar JW; Feng J; Chiang J; Moffatt E; Tseng ZH
    JAMA Intern Med; 2023 Dec; 183(12):1306-1314. PubMed ID: 37870865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death.
    Simpson TF; Salazar JW; Vittinghoff E; Probert J; Iwahashi A; Olgin JE; Ursell P; Hart A; Moffatt E; Tseng ZH
    JAMA Intern Med; 2020 May; 180(5):698-706. PubMed ID: 32119028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
    Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
    JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical Dispersion Discriminates between Arrhythmic and Non-Arrhythmic Sudden Death: From the POST SCD Study.
    Tastet L; Ramakrishna S; Lim LJ; Bibby D; Olgin JE; Connolly AJ; Moffatt E; Tseng ZH; Delling FN
    medRxiv; 2023 May; ():. PubMed ID: 37293041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antemortem and Post-Mortem Characteristics of Lethal Mitral Valve Prolapse Among All Countywide Sudden Deaths.
    Delling FN; Aung S; Vittinghoff E; Dave S; Lim LJ; Olgin JE; Connolly A; Moffatt E; Tseng ZH
    JACC Clin Electrophysiol; 2021 Aug; 7(8):1025-1034. PubMed ID: 33640349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
    Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
    Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.
    Chia YMF; Teng TK; Tan ESJ; Tay WT; Richards AM; Chin CWL; Shimizu W; Park SW; Hung CL; Ling LH; Ngarmukos T; Omar R; Siswanto BB; Narasimhan C; Reyes EB; Yu CM; Anand I; MacDonald MR; Yap J; Zhang S; Finkelstein EA; Lam CSP
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29150533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis.
    Rohde LE; Chatterjee NA; Vaduganathan M; Claggett B; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    JACC Heart Fail; 2020 Oct; 8(10):844-855. PubMed ID: 32919916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.
    Rørth R; Dewan P; Kristensen SL; Jhund PS; Petrie MC; Køber L; McMurray JJV
    Clin Res Cardiol; 2019 Aug; 108(8):868-877. PubMed ID: 30689020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of sudden cardiac death in Japanese heart failure patients: international validation of the Seattle Proportional Risk Model.
    Fukuoka R; Kohno T; Kohsaka S; Shiraishi Y; Sawano M; Abe T; Nagatomo Y; Goda A; Mizuno A; Fukuda K; Shadman R; Dardas TF; Levy WC; Yoshikawa T
    Europace; 2020 Apr; 22(4):588-597. PubMed ID: 32155253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.
    Schrage B; Lund LH; Benson L; Dahlström U; Shadman R; Linde C; Braunschweig F; Levy WC; Savarese G
    Eur J Heart Fail; 2022 Jul; 24(7):1212-1222. PubMed ID: 35502681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.
    Sharma A; Wu J; Xu H; Hernandez A; Felker GM; Al-Khatib S; Green J; Matsouaka R; Fonarow GC; Singh JP; Heidenreich PA; Ezekowitz JA; DeVore A
    J Am Heart Assoc; 2020 Jun; 9(12):e012405. PubMed ID: 32476539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.